Phase 2 Study of Neoadjuvant FGFR Inhibition and Androgen Deprivation Therapy Prior to Prostatectomy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase 2 Study of Neoadjuvant FGFR Inhibition and Androgen Deprivation Therapy Prior to Prostatectomy
Authors
Keywords
High-risk prostate cancer, Surgery, FGF, Pathological respose, Safety
Journal
Clinical Genitourinary Cancer
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-05-19
DOI
10.1016/j.clgc.2022.05.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Outcomes Post Neoadjuvant Intense Hormone Therapy and Surgery for Patients with High-Risk Localized Prostate Cancer: Results of a Pooled Analysis of Contemporary Clinical Trials
- (2021) Rana R. McKay et al. JOURNAL OF UROLOGY
- Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer
- (2020) James A. Eastham et al. JOURNAL OF CLINICAL ONCOLOGY
- The FGF/FGFR system in the physiopathology of the prostate gland
- (2020) Arianna Giacomini et al. PHYSIOLOGICAL REVIEWS
- Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma
- (2019) Yohann Loriot et al. NEW ENGLAND JOURNAL OF MEDICINE
- FGF2 and EGF induce epithelial–mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal
- (2018) Karin Schelch et al. CARCINOGENESIS
- Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05)
- (2018) Yoon Ji Choi et al. Cancer Research and Treatment
- Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation
- (2016) RYOTA KURIMOTO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- FGFR signaling maintains a drug persistent cell population following epithelial-mesenchymal transition
- (2016) Wells S. Brown et al. Oncotarget
- Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors
- (2016) Shu Feng et al. Oncotarget
- Organoid Cultures Derived from Patients with Advanced Prostate Cancer
- (2014) Dong Gao et al. CELL
- Identification of Multipotent Luminal Progenitor Cells in Human Prostate Organoid Cultures
- (2014) Wouter R. Karthaus et al. CELL
- Activation of FGF2-FGFR Signaling in the Castrated Mouse Prostate Stimulates the Proliferation of Basal Epithelial Cells1
- (2013) Manabu Kato et al. BIOLOGY OF REPRODUCTION
- Next-generation Sequencing of Advanced Prostate Cancer Treated with Androgen-deprivation Therapy
- (2013) Prabhakar Rajan et al. EUROPEAN UROLOGY
- Prostatic microenvironment in senescence: fibroblastic growth factors × hormonal imbalance
- (2013) A. C. Hetzl et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Formation of Human Prostate Epithelium Using Tissue Recombination of Rodent Urogenital Sinus Mesenchyme and Human Stem Cells
- (2013) Yi Cai et al. Jove-Journal of Visualized Experiments
- Tumor Volume in Radical Prostatectomy Specimens Assessed by Digital Image Analysis Software Correlates With Other Prognostic Factors
- (2010) Justin C. Sherwin et al. JOURNAL OF UROLOGY
- Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03
- (2009) Mark S. Roh et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk Assessment for Prostate Cancer Metastasis and Mortality at the Time of Diagnosis
- (2009) Matthew R. Cooperberg et al. JNCI-Journal of the National Cancer Institute
- Fibroblast Growth Factor 2 and Estrogen Control the Balance of Histone 3 Modifications Targeting MAGE-A3 in Pituitary Neoplasia
- (2008) X. Zhu et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started